Reconnect Labs is a Swiss, clinical stage biotech company designing precision therapeutics that restore mental balance — bridging science and human connection.
We’re not just developing drugs—we’re redefining mental health care.
Precision drug targets: Activating key areas of the brain, like the "blue dot" for sleep.
Proven compounds: Derisked molecules reformulated for safety and efficacy.
Restorative: Modulating mental states with precision, not sedation.
Whole-system approach: Addressing bio, psycho, and social dimensions of mental health.
How we’re different:
OTHERS target single biological factors. WE treat the whole system.
OTHERS dull negative symptoms. WE amplify positive traits.
OTHERS suppress, sedate, and manage. WE restore, uplift, and strengthen.
22.10.2025
Promising results in oncology research (startupticker.ch)
20.08.2025
Reconnect Labs emerges from stealth mode fully funded (startupticker.ch)
05.11.2024
Bio Europe in Stockholm hosts 33 Swiss companies (startupticker.ch)
16.03.2023
Swiss startups prepare to visit the US East Coast (startupticker.ch)
25.08.2022
"Innovation needs diversity" — Interview with Maria Olivares of the Innovation Hub at the University of Zürich (venturelab.swiss)
No milestones
No Jobs
Website:
reconnect-labs.com/
Headquarter:
Winterthur
Foundation Date:
March 2021
Technology:
Sectors: